Quantitative Systematic Strategies’s DexCom DXCM Stock Holding History

Quantitative Systematic Strategies’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,900	Closed	-$823K	–	643
2020 Q4	$823K	Buy	8,900 +4,908	+123%	+$438K	0.12%	282
2020 Q3	$411K	Sell	3,992 -2,468	-38%	-$258K	0.07%	364
2020 Q2	$655K	Buy	6,460 +3,108	+93%	+$278K	0.13%	252
2020 Q1	$226K	Sell	3,352 -32,320	-91%	-$2.01M	0.18%	196
2019 Q4	$1.95M	Buy	35,672 +22,752	+176%	+$1.08M	0.29%	112
2019 Q3	$482K	Sell	12,920 -6,184	-32%	-$240K	0.11%	244
2019 Q2	$716K	Buy	+19,104	New	+$601K	0.13%	203
2018 Q4	–	Sell	-8,444	Closed	-$302K	–	727
2018 Q3	$302K	Buy	+8,444	New	+$262K	0.06%	415
2015 Q3	–	Sell	-31,640	Closed	-$626K	–	409
2015 Q2	$626K	Buy	+31,640	New	+$556K	0.14%	240

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Quantitative Systematic Strategies's DXCM Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of DexCom (DXCM) in Q1 2021, closing a stake of 8,900 shares — an estimated $823K sold.

Quantitative Systematic Strategies first reported a position in DXCM in Q2 2015 and held it in 9 quarters. The position peaked at $1.95M in Q4 2019. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

Quantitative Systematic Strategies reported no remaining DexCom position as of Q1 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 8,900 DexCom shares in Q1 2021, an estimated $823K.
Quantitative Systematic Strategies first reported a position in DexCom in Q2 2015 and held it in 9 quarters.
Quantitative Systematic Strategies's DexCom position peaked at $1.95M in Q4 2019.
730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.